Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.0002 USD 0.00(0%)
Last update at 2026-10-30T13:30:00Z
Market Cap
0.00M

Momentum Score

…

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Aspyra Inc is an OTC Pink-listed microcap with sparse public disclosures that do not clearly document a stable operating business. Long-term growth may depend on clarifying its strategic focus, executing any disclosed plan, securing financing and building revenue-generating operations; investors should monitor execution and financing milestones.

Primary risks include lack of transparency and regulatory oversight typical of Pink-listed issuers, low liquidity and high share volatility, likely need for capital raising with dilution risk, and limited operating history or an unclear business model.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
7.75M
Revenue Per Share
58.48
Gross Profit TTM
3.33M
Debt / Equity
0.53
ROE
-102.54%
Net Debt
3.95M
ROCE
-40.50%
Diluted EPS TTM
-0.07

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Type yearly yearly yearly yearly yearly
Date 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Income before tax -5.18M -4.21M -3.57M -1.69M -0.26M
Minority interest 0.00M 0.00M 0.00M 0.00M -
Net income -5.19M -4.22M -3.57M -2.50M -0.26M
Selling general administrative 6.22M 6.72M 7.25M 3.89M 3.87M
Gross profit 3.92M 4.87M 5.88M 3.51M 1.24M
Ebit -3.83M -4.20M -3.34M -1.68M -0.27M
Ebitda -2.27M -2.61M -1.96M -1.10M -0.09M
Depreciation and amortization 1.56M 1.59M 1.38M 0.58M 0.18M
Non operating income net other 0.00M 0.00M 0.00M 0.00M -
Operating income 4.70M 4.20M 3.34M 1.68M 0.27M
Other operating expenses 12.65M 14.47M 16.03M 8.89M 2.66M
Interest expense 0.78M 0.17M 0.32M 0.04M 0.00M
Extraordinary items 0.00M 0.00M 0.00M 0.00M -
Non recurring 0.02M 0.14M 0.02M 0.00M -
Other items 0.00M 0.00M 0.00M 0.00M -
Income tax expense 0.01M 0.00M 0.00M 0.81M -0.53M
Total revenue 8.53M 10.27M 12.69M 7.21M 2.39M
Total operating expenses 8.04M 9.07M 9.23M 5.19M 1.51M
Cost of revenue 4.61M 5.40M 6.81M 3.70M 1.15M
Total other income expense net -0.58M -8.41M -6.91M -3.38M -0.53M
Discontinued operations 0.00M 0.00M 0.00M 0.00M -
Net income from continuing ops -5.19M -4.22M -3.57M -2.50M -
Net income applicable to common shares -5.19M -5.01M -3.57M -2.50M 0.16M
Preferred stock and other adjustments 0.00M 0.00M 0.00M 0.00M -
Breakdown 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Type yearly yearly yearly yearly yearly
Date 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Total assets 15.16M 16.77M 19.30M 18.63M 6.59M
Intangible assets 5.92M 6.60M 6.94M 12.40M -
Other current assets 0.78M 0.13M 0.09M 0.59M 0.80M
Total liab 8.37M 6.26M 6.50M 6.44M 2.68M
Total stockholder equity 6.79M 10.51M 12.80M 12.18M 3.91M
Deferred long term liab 0.00M 0.00M 0.00M 0.00M -
Other current liab 1.62M 1.62M 1.25M 1.23M 0.55M
Common stock 22.76M 22.76M 21.04M 16.97M 6.20M
Retained earnings -18.56M -13.37M -8.36M -4.79M -2.29M
Other liab 0.00M 0.00M 0.00M 0.00M -
Good will 6.69M 7.27M 7.27M 7.70M -
Other assets 0.21M 0.16M 0.18M 0.16M 1.95M
Cash -0.35M 0.80M 1.01M 1.33M 1.66M
Total current liabilities 5.71M 5.91M 6.00M 6.22M 2.68M
Current deferred revenue 2.44M 2.16M 2.29M 2.78M 1.46M
Net debt 3.95M 0.90M 1.06M -0.11M -1.36M
Short term debt 0.95M 1.35M 1.57M 1.00M 0.30M
Short long term debt 0.74M 1.03M 1.42M 1.00M -
Short long term debt total 3.60M 1.70M 2.07M 1.22M 0.30M
Other stockholder equity 25.35M 23.94M 21.20M -0.00M -
Property plant equipment 0.50M 0.84M 1.17M 0.51M 0.18M
Total current assets 1.84M 1.90M 3.74M 3.67M 4.27M
Long term investments 0.00M 0.00M 0.00M 0.00M -
Net tangible assets -5.82M -3.35M -1.41M -2.10M -
Short term investments 0.00M 0.00M 0.03M 0.00M -
Net receivables 0.81M 0.92M 1.33M 1.55M 1.74M
Long term debt 2.46M 0.09M 0.02M 0.22M -
Inventory 0.03M 0.05M 0.11M 0.21M 0.09M
Accounts payable 0.71M 0.78M 0.89M 1.22M 0.38M
Total permanent equity 0.00M 0.00M 0.00M 0.00M -
Noncontrolling interest in consolidated entity 0.00M 0.00M 0.00M 0.00M -
Temporary equity redeemable noncontrolling interests 0.00M 0.00M 0.00M 0.00M -
Accumulated other comprehensive income -0.00M -0.06M -0.04M -0.00M -
Additional paid in capital 0.00M 0.00M 0.00M 0.00M -
Common stock total equity 0.00M 0.00M 0.00M 0.00M -
Preferred stock total equity 0.00M 0.00M 0.00M 0.00M -
Retained earnings total equity 0.00M 0.00M 0.00M 0.00M -
Treasury stock 0.00M 0.00M 0.00M 0.00M -
Accumulated amortization 0.00M 0.00M 0.00M 0.00M -
Non currrent assets other 0.21M 0.16M 0.18M 2.04M 1.72M
Deferred long term asset charges 0.00M 0.00M 0.00M 0.00M -
Non current assets total 13.32M 14.87M 15.55M 14.95M 2.32M
Capital lease obligations 0.00M 0.00M 0.00M 0.00M -
Long term debt total 0.00M 0.00M 0.00M 0.00M -
Breakdown 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Type yearly yearly yearly yearly yearly
Date 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Investments 0.00M 0.00M 0.00M 0.00M -
Change to liabilities 0.21M -0.23M -0.82M 0.47M 0.10M
Total cashflows from investing activities -0.55M -0.92M -1.22M -2.66M -
Net borrowings 2.31M -0.28M 0.10M -0.04M -
Total cash from financing activities 2.14M 2.34M 3.17M 2.98M 0.30M
Change to operating activities 0.10M 0.49M 0.27M -0.51M -
Net income -5.19M -4.22M -3.57M -2.50M -0.26M
Change in cash -0.02M -0.21M -0.32M -0.33M 0.08M
Begin period cash flow 0.80M 1.01M 1.33M 1.66M 1.57M
End period cash flow 0.78M 0.80M 1.01M 1.33M 1.66M
Total cash from operating activities -1.69M -1.62M -2.23M -0.64M 0.16M
Depreciation 1.56M 1.59M 1.38M 0.58M 0.18M
Other cashflows from investing activities -0.02M -0.21M -0.03M -0.69M -0.18M
Dividends paid 0.00M 0.00M 0.00M 0.00M -
Change to inventory 0.07M 0.11M 0.13M -0.08M 0.04M
Change to account receivables 0.19M 0.35M 0.20M 0.56M 0.27M
Sale purchase of stock 0.00M 0.43M -0.00M 0.03M -
Other cashflows from financing activities -0.55M 0.90M -1.47M -2.66M -0.38M
Change to netincome 1.48M 0.29M 0.18M 0.84M -
Capital expenditures 0.55M 0.92M 1.22M 0.33M 0.20M
Change receivables 0.00M 0.00M 0.00M 0.00M -
Cash flows other operating 0.00M 0.00M 0.00M 0.00M -
Exchange rate changes 0.00M 0.00M 0.00M 0.00M -
Cash and cash equivalents changes 0.00M 0.00M 0.00M 0.00M -
Change in working capital 0.47M 0.71M -0.22M 0.44M 0.21M
Stock based compensation 0.44M - - - -
Other non cash items 0.02M 0.29M 0.18M 0.05M 0.04M
Free cash flow -2.24M -2.54M -3.45M -0.96M -0.04M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
APYI
Aspyra Inc
-
-%
0.00 - - - 0.01 0.00 -0.01
VEEV
Veeva Systems Inc Class A
-5.96
1.90%
307.00 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited
-4.88
3.56%
132.14 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock
5.99
8.29%
78.21 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc
-0.05
0.86%
5.75 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

Aspyra Inc

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.

7400 Baymeadows Way, Jacksonville, FL, United States, 32256

904-731-1289

69

Name Title Year Born
Mr. Gary W. Bennett Pres NA
Mr. Dennis Prichard VP of Laboratory Information Solutions Devel. & Operations NA
Mr. Gary W. Bennett President NA
Mr. Danny Chin Vice President of Operations NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…